Financial Data and Key Metrics Changes - Tempus reported a strong Q3 2025 with overall genomics volume growth of 33%, oncology growing at 27%, and hereditary testing growing at 37% [4] - The company achieved positive adjusted EBITDA for the first time, a key milestone after 10 years, with expectations for slightly positive adjusted EBITDA for the year despite additional expenses from the Paige acquisition [5] Business Line Data and Key Metrics Changes - The data licensing or insights business grew by 38% in the quarter, contributing an additional $150 million in total contract value, indicating strong bookings across multiple contracts [4][5] - The hereditary growth is expected to moderate to the low- to mid-20s percentage range, an increase from previous guidance of mid- to high teens [4] Market Data and Key Metrics Changes - The company noted that testing volumes have been healthy, with a general market tailwind as more biomarkers are identified, leading to increased patient testing [10] - Tempus is positioned well across the entire continuum of genomic testing, with strong offerings in hereditary profiling, therapy selection, and MRD monitoring [27] Company Strategy and Development Direction - Tempus aims for sustained long-term unit growth and revenue growth, targeting about 25% growth for the next three years [14][17] - The company is investing heavily in its foundation model and AI capabilities, integrating efforts from the Paige acquisition to enhance its genomic diagnostics business [42][44] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth of the genomic business, emphasizing the importance of long-term growth over short-term fluctuations [40] - The company anticipates that reimbursement for data interpretation and analysis will eventually improve, positioning Tempus favorably for future growth [48] Other Important Information - The company highlighted the differentiation of its data products, which are increasingly sought after by clients, contributing to the growth of its data licensing business [23][24] - Tempus is actively working on regulatory filings for its liquid biopsy tests, which are expected to enhance reimbursement opportunities [29] Q&A Session Summary Question: What is driving the strong growth in the oncology portfolio? - Management attributed the growth to a more efficient sales force and the integration of technology that provides comprehensive results to physicians, alongside general market trends in testing volumes [9][10] Question: How is Tempus planning to market MRD testing? - The company plans to gradually increase MRD testing as reimbursement becomes available, leveraging its trained sales force and a strong portfolio of assays [16][17] Question: Can you provide details on the $150 million in new contracts? - Management explained that the disclosure of significant contracts is made when they rise to a level worth highlighting, emphasizing that these are multi-year deals and do not directly translate to immediate revenue [20][21] Question: What is the outlook for the hereditary cancer testing market? - Management indicated that Ambry's growth is expected to moderate but remains strong, with the hereditary business anticipated to grow in the low to mid-20s percentage range [32][33] Question: How does the Paige acquisition enhance Tempus's capabilities? - The integration of Paige.AI is expected to improve sequencing outcomes and speed up result delivery through digital pathology algorithms, enhancing the overall diagnostic capabilities [52][54]

Core Insights - Reddit's stock experienced a nearly 5% increase on Friday after a significant drop earlier in the week, where it lost over 10% on Wednesday and an additional 1% on Thursday, resulting in a total decline of 13% for the week [1][6]. Stock Performance - The stock has surged nearly 500% from its IPO price in March 2024, driven by strong user growth and a rapidly expanding advertising business [5]. - However, shares have retreated nearly 30% from a record high of 282.95 on September 18 [6]. - Reddit's Relative Strength Rating remains strong at 97 out of a best-possible 99, indicating its outperformance over the past 12 months [6]. Analyst Opinions - Piper Sandler analyst Thomas Champion maintains an overweight rating on Reddit with a target price of 290, asserting that ChatGPT is not a major traffic source for Reddit [2][3]. - Champion believes that the relationship with Google remains intact and expects a solid quarter for Reddit [3]. - Citizen JMP analyst Andrew Boone also expresses a bullish outlook, stating that concerns regarding Reddit's search-engine optimization are "simply noise" and emphasizes the potential for stronger monetization of logged-in users [3][4]. - Boone rates Reddit as outperform with a target price of 300, focusing on the momentum in the advertising business [4]. Ratings - Reddit stock holds an IBD Composite Rating of 94, indicating strong growth potential as the best growth stocks typically have a Composite Rating of 90 to 99 [7].

Financial Data and Key Metrics Changes - Quarterly revenue grew by 53% year over year from $12.4 million to $19 million, exceeding guidance [6][27] - Net income improved by nearly $3 million year over year, reaching $800,000 or $0.01 per share [7][28] - Adjusted EBITDA increased by over $4 million year over year from negative $1 million to positive $3 million, marking the highest adjusted EBITDA in company history [7][28] - Adjusted free cash flow was $2.9 million, representing the sixth consecutive quarter of positive adjusted free cash flow [29] Business Line Data and Key Metrics Changes - Subscription revenue was $9.3 million, a decline of $1.7 million from last year but a sequential increase from Q1 [29] - Content licensing revenue was $9.3 million, an increase of over $8 million driven by significant new business from AI licensing [29] - Gross margin improved slightly to 53% from 52% a year ago, with reductions in content amortization [30] Market Data and Key Metrics Changes - The company has entered into new and expanded multiyear wholesale distribution agreements in Asia, Latin America, and the U.S., which are expected to boost subscription revenue [8] - The dataset licensing for AI training has grown substantially for three consecutive quarters, including licensing about 9 million tokens of code for the first time [10][11] Company Strategy and Development Direction - The company aims to have three solid revenue pillars: subscription business, licensing business, and advertising business, with expectations for steady growth in subscriptions and rapid growth in licensing [37] - The company is focused on becoming a dominant AI video licensor, with plans to license more video and data than in 2025 [24][25] - The company emphasizes the importance of its extensive library of over 1 million hours of content and its ability to structure data effectively as competitive advantages [19][21] Management's Comments on Operating Environment and Future Outlook - Management believes the market for high-quality, ethically sourced video and audio content is durable and growing, with estimates of industry-wide needs ranging from billions to tens of billions of hours [14][15] - The company is confident in its ability to navigate the evolving landscape of AI and media, focusing on meaningful information while disregarding distractions [22][23] - The company maintains a strong balance sheet with $31 million in liquidity and no debt, positioning itself as a high-performance outlier amid technological revolution [25][31] Other Important Information - The company paid dividends of $10.4 million in June, including a special dividend of $5.8 million, resulting in a dividend yield of about 6.5% [31] - The company expects third-quarter revenue in the range of $15 million to $18 million and adjusted free cash flow for 2025 in the range of $11 million to $13 million [32] Q&A Session Summary Question: Why is the company in the core media business? - Management stated that the subscription video on demand business is strong and global, representing the core of the company, and that all revenue streams work together synergistically [36][37] Question: What are the expected cost increases as the company pivots towards high-growth licensing? - Management indicated that the primary costs would be related to storage and delivery, but overall costs would remain manageable due to existing revenue-sharing arrangements [40][41] Question: What is the significance of licensing code for AI training? - Management explained that while video is the primary focus, the inclusion of code in licensing is a unique opportunity that reflects the value of owning and controlling intellectual property [49][50] Question: Is the company exploring other types of video content for licensing? - Management confirmed that while the focus remains on building a factual entertainment library, there is potential value in other types of video content, particularly if they are not freely available [53][55]